Evidence map›Paper›PMID 34075043›Full record

ArticleNature communications2021

Zinc drives vasorelaxation by acting in sensory nerves, endothelium and smooth muscle.

Ashenafi H Betrie, James A Brock, Osama F Harraz, Ashley I Bush, Guo-Wei He, Mark T Nelson, James A Angus, Christine E Wright, Scott Ayton

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Myocardial TRPC6-mediated ZnNature communications · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 4 countries.

Ashenafi H BetrieMelbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria, Australia.ORCID 0000-0002-8196-8042
James A BrockDepartment of Anatomy and Physiology, The University of Melbourne, Victoria, Australia.ORCID 0000-0002-1381-1983
Osama F HarrazDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.ORCID 0000-0003-2061-1100
Ashley I BushMelbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria, Australia.ORCID 0000-0001-8259-9069
Guo-Wei HeDepartment of Cardiovascular Surgery & Center for Basic Medical Research, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences; The Institute of Cardiovascular Diseases, Tianjin University, Tianjin; Center for Drug Development, Wannan Medical College, Wuhu, Anhui, China.ORCID 0000-0001-6497-876X
Mark T NelsonDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.
James A AngusCardiovascular Therapeutics Unit, Department of Biochemistry and Pharmacology, The University of Melbourne, Victoria, Australia.
Christine E WrightCardiovascular Therapeutics Unit, Department of Biochemistry and Pharmacology, The University of Melbourne, Victoria, Australia. cewright@unimelb.edu.au.ORCID 0000-0002-3339-040X
Scott AytonMelbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria, Australia. scott.ayton@florey.edu.au.
The University of Melbourne · AUUniversity of Vermont · USWannan Medical College · CN

Funding

Vermont Center for Cardiovascular and Brain HealthP20GM135007 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Kathryn H Morelli · 2020 to 2026
$17.4M
Impact of SAH on Parenchymal Arterioles and Neurovascular CouplingP01HL095488 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BONEV, ADRIAN · 2010 to 2014
$11.4M
Capillaries as a Sensory Web that Controls Cerebral Blood Flow in Health and DiseaseR35HL140027 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2019 to 2025
$6.3M
Ca2+ Sparks and Urinary Bladder Smooth Muscle ExcitabilityR37DK053832 · NIDDK · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2008 to 2017
$3.4M
Ion Channel Dysfunction in Small Vessel Disease of the BrainR01NS110656 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2019 to 2023
$2.6M
Regulations of Myoendothelial Function By Signaling Microdomains in HypertensionR01HL121706 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2014 to 2017
$1.6M
K+ sensing & electrical signaling by Kir channels in brain vasculatureR01HL131181 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2016 to 2018
$1.4M
American Heart Association-American Stroke Association 17POST33650030American Heart Association-American Stroke Association 20CDA35310097 - OSAMA HARRAZNHLBI NIH HHS P01 HL095488NHLBI NIH HHS R01 HL121706NHLBI NIH HHS R01 HL131181NHLBI NIH HHS R35 HL140027NIDDK NIH HHS R37 DK053832NIGMS NIH HHS P20 GM135007NINDS NIH HHS R01 NS110656
6 · The paper itself

Abstract

Zinc, an abundant transition metal, serves as a signalling molecule in several biological systems. Zinc transporters are genetically associated with cardiovascular diseases but the function of zinc in vascular tone regulation is unknown. We found that elevating cytoplasmic zinc using ionophores relaxed rat and human isolated blood vessels and caused hyperpolarization of smooth muscle membrane. Furthermore, zinc ionophores lowered blood pressure in anaesthetized rats and increased blood flow without affecting heart rate. Conversely, intracellular zinc chelation induced contraction of selected vessels from rats and humans and depolarized vascular smooth muscle membrane potential. We demonstrate three mechanisms for zinc-induced vasorelaxation: (1) activation of transient receptor potential ankyrin 1 to increase calcitonin gene-related peptide signalling from perivascular sensory nerves; (2) enhancement of cyclooxygenase-sensitive vasodilatory prostanoid signalling in the endothelium; and (3) inhibition of voltage-gated calcium channels in the smooth muscle. These data introduce zinc as a new target for vascular therapeutics.

Indexed as

AgedAnimalsBlood PressureCalcitonin Gene-Related PeptideCalcium Channels, N-TypeChelating AgentsCytoplasmEndothelium, VascularEthylenediaminesFemaleHEK293 CellsHumansMaleMiceMice, KnockoutMiddle AgedCalcitonin Gene-Related PeptideCalcium Channels, N-TypeChelating AgentsEthylenediaminesN,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamineProstaglandin-Endoperoxide SynthasesProstaglandinsTRPA1 Cation ChannelZinc

Identifiers

PMID34075043
PMCPMC8169932
OpenAlexW3164600373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.